{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:29:03Z","timestamp":1773451743497,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jgo.2021.10.008","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T13:23:31Z","timestamp":1635341011000},"page":"294-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials"],"prefix":"10.1016","volume":"13","author":[{"given":"Noam","family":"VanderWalde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Moughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart M.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reshma","family":"Jagsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Ballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"VanderWalde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Mohiuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal J.","family":"Meropol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Kachnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaffer","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rani","family":"Anne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith L.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susannah G.","family":"Ellsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeffrey","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2021.10.008_bb0005","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","article-title":"Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal","volume":"51","author":"Nigro","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2021.10.008_bb0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2021.10.008_bb0015","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199103143241101","article-title":"Effective surgical adjuvant therapy for high-risk rectal carcinoma","volume":"324","author":"Krook","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2021.10.008_bb0025","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2021.10.008_bb0030","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0035","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv248","article-title":"Neoadjuvant 5-FU or capecitabine plus radiation with or without Oxaliplatin in rectal cancer patients: a phase III randomized clinical trial","volume":"107","author":"Allegra","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jgo.2021.10.008_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jgo.2021.10.008_bb0050","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","article-title":"Future of cancer incidence in the United States: burdens upon an aging, changing nation","volume":"27","author":"Smith","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0055","doi-asserted-by":"crossref","first-page":"286","DOI":"10.6004\/jnccn.2012.0025","article-title":"Research priorities in geriatric oncology: addressing the needs of an aging population","volume":"10","author":"Hurria","year":"2012","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jgo.2021.10.008_bb0060","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/030089161209800513","article-title":"Effects of preoperative radiochemotherapy with capecitabine for resectable locally advanced rectal cancer in elderly patients","volume":"98","author":"Ausili Cefaro","year":"2012","journal-title":"Tumori"},{"key":"10.1016\/j.jgo.2021.10.008_bb0065","doi-asserted-by":"crossref","first-page":"610786","DOI":"10.1155\/2013\/610786","article-title":"Preoperative chemoradiotherapy in elderly patients with locally advanced rectal cancer","volume":"2013","author":"De Felice","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jgo.2021.10.008_bb0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0399-8320(07)89407-3","article-title":"Preoperative radiotherapy in elderly patients with rectal cancer","volume":"31","author":"Lorchel","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<26::AID-CNCR4>3.0.CO;2-0","article-title":"Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy","volume":"85","author":"Allal","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2021.10.008_bb0080","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.ijrobp.2011.12.062","article-title":"Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort","volume":"83","author":"Bentzen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jgo.2021.10.008_bb0085","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6602486","article-title":"Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy","volume":"92","author":"Charnley","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgo.2021.10.008_bb0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.dld.2014.01.004","article-title":"Results of age-dependent anal canal cancer treatment: a single Centre retrospective study","volume":"46","author":"Claren","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jgo.2021.10.008_bb0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.critrevonc.2006.09.003","article-title":"Anal carcinoma of the elderly treated with radiotherapy alone or with concomitant radio-chemotherapy","volume":"61","author":"Fallai","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0100","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3109\/0284186X.2013.876513","article-title":"Impact of advancing age on treatment and outcomes in anal cancer","volume":"53","author":"Foo","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/02841860600849075","article-title":"Chemoradiotherapy of anal cancer is feasible in elderly patients: treatment results of mitomycin-5-FU combined with radiotherapy at Helsinki University Central Hospital 1992-2003","volume":"45","author":"Saarilahti","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0110","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1387::AID-CNCR4>3.0.CO;2-C","article-title":"Is chemoradiation feasible in elderly patients? A study of 17 patients with anorectal carcinoma","volume":"80","author":"Valentini","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2021.10.008_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-8140(96)01861-0","article-title":"Age is not a limiting factor for radical radiotherapy in pelvic malignancies","volume":"42","author":"Pignon","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0120","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijrobp.2013.02.020","article-title":"Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer","volume":"86","author":"Mohiuddin","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jgo.2021.10.008_bb0125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ijrobp.2011.05.027","article-title":"Radiation therapy oncology group 0247: a randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer","volume":"82","author":"Wong","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jgo.2021.10.008_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2015.05.005","article-title":"NRG oncology radiation therapy oncology group 0822: a phase 2 study of preoperative Chemoradiation therapy using intensity modulated radiation therapy in combination with Capecitabine and Oxaliplatin for patients with locally advanced rectal Cancer","volume":"93","author":"Hong","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jgo.2021.10.008_bb0135","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1200\/JCO.2013.53.7753","article-title":"Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and bowel project trial R-04","volume":"32","author":"O\u2019Connell","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0140","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0145","first-page":"1","article-title":"United States life tables, 2014","volume":"66","author":"Arias","year":"2017","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.jgo.2021.10.008_bb0150","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ijrobp.2017.12.261","article-title":"Decision-making strategy for rectal Cancer management using radiation therapy for elderly or comorbid patients","volume":"100","author":"Wang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jgo.2021.10.008_bb0155","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.radonc.2013.10.019","article-title":"Results in the elderly with locally advanced rectal cancer from the ACCOR12\/PRODIGE 2 phase III trial: tolerance and efficacy","volume":"110","author":"Francois","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jgo.2021.10.008_bb0160","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel","volume":"76","author":"Kavanagh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jgo.2021.10.008_bb0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jncimonographs\/lgh031","article-title":"Symptom management in the elderly cancer patient: fatigue, pain, and depression","author":"Rao","year":"2004","journal-title":"J Natl Cancer Inst Monogr"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187940682100240X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187940682100240X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:54:32Z","timestamp":1761818072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187940682100240X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S187940682100240X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2021.10.008","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2021.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}